Michael Andrew Holloway

Insider Reports History

Location
Vancouver
Signature
/s/ Michael Holloway
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Andrew Holloway:

Company Role Class Num Shares Value Price $ Report Date Ownership
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Director Options to Purchase Common Stock 25,000 15 Aug 2025 Direct

Insider Reports Filed by Michael Andrew Holloway

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. 15 Aug 2025 1 $0 4 Director 18 Aug 2025, 14:56
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. 18 Jul 2025 0 $0 3 Director 21 Jul 2025, 16:37